{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:19:36Z","timestamp":1772605176916,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11427-012-4301-3","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T08:16:15Z","timestamp":1334304975000},"page":"219-227","source":"Crossref","is-referenced-by-count":11,"title":["Establishment of a transgenic mouse model with liver-specific expression of secretory immunoglobulin D"],"prefix":"10.1007","volume":"55","author":[{"given":"Ping","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhiGuo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BoWen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KeMian","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YunPing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MeiLi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XueQian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiFeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,14]]},"reference":[{"key":"4301_CR1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.52.10.765-b","volume":"52","author":"J. P. Drenth","year":"1993","unstructured":"Drenth J P, Prieur A M. Occurrence of arthritis in hyper-immunoglobulinaemia D. Ann Rheum Dis, 1993, 52: 765\u2013766","journal-title":"Ann Rheum Dis"},{"key":"4301_CR2","first-page":"59","volume":"130","author":"J. P. Drenth","year":"1994","unstructured":"Drenth J P, Boom B W, Toonstra J, et al. Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. Arch Dermatol, 1994, 130: 59\u201365","journal-title":"International Hyper IgD Study Group. Arch Dermatol"},{"key":"4301_CR3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","volume":"73","author":"J. P. Drenth","year":"1994","unstructured":"Drenth J P, Haagsma C J, van der Meer J W. Hyperimmuno-globulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore), 1994, 73: 133\u2013144","journal-title":"Medicine (Baltimore)"},{"key":"4301_CR4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(84)92505-4","volume":"1","author":"J. W. Meer van der","year":"1984","unstructured":"van der Meer J W, Vossen J M, Radl J, et al. Hyperimmuno-globulinaemia D and periodic fever: a new syndrome. Lancet, 1984, 1: 1087\u20131090","journal-title":"Lancet"},{"key":"4301_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/s10165-008-0130-4","volume":"19","author":"T. Naruto","year":"2009","unstructured":"Naruto T, Nakagishi Y, Mori M, et al. Hyper-IgD syndrome with novel mutation in a Japanese girl. Mod Rheumatol, 2009, 19: 96\u201399","journal-title":"Mod Rheumatol"},{"key":"4301_CR6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1442-200X.2002.01541.x","volume":"44","author":"K. Yoshimura","year":"2002","unstructured":"Yoshimura K, Wakiguchi H. Hyperimmunoglobulinemia D syndrome successfully treated with a corticosteroid. Pediatr Int, 2002, 44: 326\u2013327","journal-title":"Pediatr Int"},{"key":"4301_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/CDLI.8.1.58-61.2001","volume":"8","author":"I. S. Klasen","year":"2001","unstructured":"Klasen I S, Goertz J H, van de Wiel G A, et al. Hyper-immuno-globulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immun, 2001, 8: 58\u201361","journal-title":"Clin Diagn Lab Immun"},{"key":"4301_CR8","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.10550","volume":"46","author":"J. Frenkel","year":"2002","unstructured":"Frenkel J, Rijkers G T, Mandey S H, et al. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmuno-globulinemia D and periodic fever syndrome. Arthrit Rheumat, 2002, 46: 2794\u20132803","journal-title":"Arthrit Rheumat"},{"key":"4301_CR9","first-page":"178","volume":"22","author":"J. P. Drenth","year":"1999","unstructured":"Drenth J P, Cuisset L, Grateau G, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet, 1999, 22: 178\u2013181","journal-title":"International Hyper-IgD Study Group. Nat Genet"},{"key":"4301_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-135-5-200109040-00010","volume":"135","author":"A. Simon","year":"2001","unstructured":"Simon A, Cuisset L, Vincent M F, et al. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med, 2001, 135: 338\u2013343","journal-title":"Ann Intern Med"},{"key":"4301_CR11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.ejhg.5200933","volume":"11","author":"S. M. Houten","year":"2003","unstructured":"Houten S M, van Woerden C S, Wijburg F A, et al. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet, 2003, 11: 196\u2013200","journal-title":"Eur J Hum Genet"},{"key":"4301_CR12","first-page":"8","volume":"31","author":"M. Aringer","year":"2004","unstructured":"Aringer M. Periodic fever syndromes\u2014a clinical overview. Acta Med Austriaca, 2004, 31: 8\u201312","journal-title":"Acta Med Austriaca"},{"key":"4301_CR13","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra010200","volume":"345","author":"J. P. Drenth","year":"2001","unstructured":"Drenth J P, van der Meer J W. Hereditary periodic fever. N Engl J Med, 2001, 345: 1748\u20131757","journal-title":"N Engl J Med"},{"key":"4301_CR14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s10545-007-0776-7","volume":"30","author":"E. J. Hager","year":"2007","unstructured":"Hager E J, Tse H M, Piganelli J D, et al. Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome. J Inherit Metab Dis, 2007, 30: 888\u2013895","journal-title":"J Inherit Metab Dis"},{"key":"4301_CR15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/rheumatology\/kem200","volume":"46","author":"W. Ammouri","year":"2007","unstructured":"Ammouri W, Cuisset L, Rouaghe S, et al. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology, 2007, 46: 1597\u20131600","journal-title":"Rheumatology"},{"key":"4301_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00412695","volume":"265","author":"T. C. Dikeacou","year":"1979","unstructured":"Dikeacou T C, van Joost T, Cormane R H. The recruitment of inflammatory cells using the skin-window technique. Arch Dermatol Res, 1979, 265: 1\u20137","journal-title":"Arch Dermatol Res"},{"key":"4301_CR17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2010.00929.x","volume":"237","author":"K. Chen","year":"2010","unstructured":"Chen K, Cerutti A. New insights into the enigma of immunoglobulin D. Immunol Rev, 2010, 237: 160\u2013179","journal-title":"Immunol Rev"},{"key":"4301_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/CDLI.7.2.131-140.2000","volume":"7","author":"A. O. Vladutiu","year":"2000","unstructured":"Vladutiu A O. Immunoglobulin D: properties, measurement, and clinical relevance. Clin Diagn Lab Immun, 2000, 7: 131\u2013140","journal-title":"Clin Diagn Lab Immun"},{"key":"4301_CR19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0092-8674(86)90519-2","volume":"47","author":"K. Gorski","year":"1986","unstructured":"Gorski K, Carneiro M, Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell, 1986, 47: 767\u2013776","journal-title":"Cell"},{"key":"4301_CR20","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1128\/MCB.9.11.4750","volume":"9","author":"P. Herbomel","year":"1989","unstructured":"Herbomel P, Rollier A, Tronche F, et al. The rat albumin promoter is composed of six distinct positive elements within 130 nucleotides. Mol Cell Biol, 1989, 9: 4750\u20134758","journal-title":"Mol Cell Biol"},{"key":"4301_CR21","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/MCB.7.7.2425","volume":"7","author":"J. M. Heard","year":"1987","unstructured":"Heard J M, Herbomel P, Ott M O, et al. Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system. Mol Cell Biol, 1987, 7: 2425\u20132434","journal-title":"Mol Cell Biol"},{"key":"4301_CR22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1546-0096-7-14","volume":"7","author":"C. L. Kraus","year":"2009","unstructured":"Kraus C L, Culican S M. Nummular keratopathy in a patient with Hyper-IgD Syndrome. Pediatr Rheumatol Online J, 2009, 7: 14","journal-title":"Pediatr Rheumatol Online J"},{"key":"4301_CR23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00431-008-0843-6","volume":"168","author":"M. Sornsakrin","year":"2009","unstructured":"Sornsakrin M, Wenner K, Ganschow R. B cell cytopenia in two brothers with hyper-IgD and periodic fever syndrome. Eur J Pediatr, 2009, 168: 825\u2013831","journal-title":"Eur J Pediatr"},{"key":"4301_CR24","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.ejim.2008.04.009","volume":"19","author":"H. Attout","year":"2008","unstructured":"Attout H, Guez S, Ranaivo I, et al. A patient with hyper-IgD syndrome responding to simvastatin treatment. Eur J Intern Med, 2008, 19: e82\u201383","journal-title":"Eur J Intern Med"},{"key":"4301_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10067-003-0858-3","volume":"23","author":"E. Coban","year":"2004","unstructured":"Coban E, Terzioglu E. A patient with hyper-IgD syndrome in Antalya, Turkey. Clin Rheumatol, 2004, 23: 177\u2013178","journal-title":"Clin Rheumatol"},{"key":"4301_CR26","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1128\/MCB.9.11.4759","volume":"9","author":"F. Tronche","year":"1989","unstructured":"Tronche F, Rollier A, Bach I, et al. The rat albumin promoter: cooperation with upstream elements is required when binding of APF\/HNF1 to the proximal element is partially impaired by mutation or bacterial methylation. Mol Cell Biol, 1989, 9: 4759\u20134766","journal-title":"Mol Cell Biol"},{"key":"4301_CR27","doi-asserted-by":"crossref","first-page":"21179","DOI":"10.1016\/S0021-9258(18)54837-7","volume":"266","author":"D. E. Zhang","year":"1991","unstructured":"Zhang D E, Ge X, Rabek J P, et al. Functional analysis of the trans-acting factor binding sites of the mouse alpha-fetoprotein proximal promoter by site-directed mutagenesis. J Biol Chem, 1991, 266: 21179\u201321185","journal-title":"J Biol Chem"},{"key":"4301_CR28","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1016\/S0021-9258(18)60510-1","volume":"264","author":"M. G. Izban","year":"1989","unstructured":"Izban M G, Papaconstantinou J. Cell-specific expression of mouse albumin promoter\u2014evidence for cell-specific DNA elements within the proximal promoter region and cis-acting DNA elements upstream of \u2212160. J Biol Chem, 1989, 264: 9171\u20139179","journal-title":"J Biol Chem"},{"key":"4301_CR29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1101\/gad.1.3.268","volume":"1","author":"C. A. Pinkert","year":"1987","unstructured":"Pinkert C A, Ornitz D M, Brinster R L, et al. An albumin enhancer located 10-kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Gene Dev, 1987, 1: 268\u2013276","journal-title":"Gene Dev"},{"key":"4301_CR30","first-page":"577","volume":"3","author":"J. M. Hu","year":"1992","unstructured":"Hu J M, Camper S A, Tilghman S M, et al. Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes. Cell Growth Differ, 1992, 3: 577\u2013588","journal-title":"Cell Growth Differ"},{"key":"4301_CR31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nbt1192-1450","volume":"10","author":"A. J. Clark","year":"1992","unstructured":"Clark A J, Cowper A, Wallace R, et al. Rescuing transgene expression by co-integration. Biotechnology (NY), 1992, 10: 1450\u20131454","journal-title":"Biotechnology (NY)"},{"key":"4301_CR32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11248-007-9162-3","volume":"17","author":"B. Tang","year":"2008","unstructured":"Tang B, Yu S, Zheng M, et al. High level expression of a functional human\/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice. Transgenic Res, 2008, 17: 727\u2013732","journal-title":"Transgenic Res"},{"key":"4301_CR33","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1128\/JVI.72.5.3762-3772.1998","volume":"72","author":"L. Enjuanes","year":"1998","unstructured":"Enjuanes L, Sola I, Castilla J, et al. Transgenic mice secreting coronavirus neutralizing antibodies into the milk. J Virology, 1998, 72: 3762\u20133772","journal-title":"J Virology"},{"key":"4301_CR34","first-page":"119","volume":"21","author":"J. M. Fine","year":"1974","unstructured":"Fine J M, Rivat C, Lambin P, et al. Monoclonal IgD. A comparative study of 60 sera with IgD \u201cM\u201d component. Biomedicine, 1974, 21: 119\u2013125","journal-title":"A comparative study of 60 sera with IgD \u201cM\u201d component. Biomedicine"},{"key":"4301_CR35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0609.1984.tb00727.x","volume":"33","author":"W. E. Fibbe","year":"1984","unstructured":"Fibbe W E, Jansen J. Prognostic factors in IgD myeloma: a study of 21 cases. Scand J Haematol, 1984, 33: 471\u2013475","journal-title":"Scand J Haematol"},{"key":"4301_CR36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1084\/jem.138.4.965","volume":"138","author":"D. S. Rowe","year":"1973","unstructured":"Rowe D S, Hug K, Forni L, et al. Immunoglobulin-D as a lymphocyte receptor. J Exp Med, 1973, 138: 965\u2013972","journal-title":"J Exp Med"},{"key":"4301_CR37","first-page":"15","volume":"55","author":"G. J. Ligthart","year":"1985","unstructured":"Ligthart G J, Schuit H R, Hijmans W. Subpopulations of mononuclear cells in ageing: expansion of the null cell compartment and decrease in the number of T and B cells in human blood. Immunology, 1985, 55: 15\u201321","journal-title":"Immunology"},{"key":"4301_CR38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1748","volume":"10","author":"K. Chen","year":"2009","unstructured":"Chen K, Xu W, Wilson M, et al. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol, 2009, 10: 889\u2013898","journal-title":"Nat Immunol"},{"key":"4301_CR39","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/art.20490","volume":"50","author":"L. Obici","year":"2004","unstructured":"Obici L, Manno C, Muda A O, et al. First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum, 2004, 50: 2966\u20132969","journal-title":"Arthritis Rheum"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-012-4301-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11427-012-4301-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-012-4301-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T20:34:25Z","timestamp":1642019665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-012-4301-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["4301"],"URL":"https:\/\/doi.org\/10.1007\/s11427-012-4301-3","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}